These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Measurement of delta 1-tetrahydrocannabinol in plasma to the low picogram range by gas chromatography-mass spectrometry using metastable ion detection. Harvey DJ; Leuschner JT; Paton WD J Chromatogr; 1980 Dec; 202(1):83-92. PubMed ID: 6260826 [TBL] [Abstract][Full Text] [Related]
9. Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. Johansson EK; Hollister LE; Halldin MM NIDA Res Monogr; 1989; 95():457-8. PubMed ID: 2561839 [TBL] [Abstract][Full Text] [Related]
10. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. Johansson E; Halldin MM J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702 [TBL] [Abstract][Full Text] [Related]
11. GC-MS-MS confirmation of unusually high delta 9-tetrahydrocannabinol levels in two postmortem blood samples. Collins M; Easson J; Hansen G; Hodda A; Lewis K J Anal Toxicol; 1997; 21(7):538-42. PubMed ID: 9399122 [TBL] [Abstract][Full Text] [Related]
12. Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use. Westin AA; Huestis MA; Aarstad K; Spigset O J Anal Toxicol; 2009; 33(9):610-4. PubMed ID: 20040136 [TBL] [Abstract][Full Text] [Related]
13. Ultrasensitive measurement of delta-9-tetrahydrocannabinol with a high energy dynode detector and electron-capture negative chemical-ionization mass spectrometry. Shaw LM; Edling-Owens J; Mattes R Clin Chem; 1991 Dec; 37(12):2062-8. PubMed ID: 1662560 [TBL] [Abstract][Full Text] [Related]
14. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. Huestis MA; Mitchell JM; Cone EJ J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681 [TBL] [Abstract][Full Text] [Related]
15. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes. Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012 [TBL] [Abstract][Full Text] [Related]
16. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH). Huestis MA; Henningfield JE; Cone EJ J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216 [TBL] [Abstract][Full Text] [Related]
17. Confirmation of cannabis use. III. Simultaneous quantitation of six metabolites of delta 9-tetrahydrocannabinol in plasma by high-performance liquid chromatography with electrochemical detection. Nakahara Y; Cook CE J Chromatogr; 1988 Dec; 434(1):247-52. PubMed ID: 2854134 [No Abstract] [Full Text] [Related]
18. Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking. Kelly TH; Foltin RW; Emurian CS; Fischman MW J Exp Anal Behav; 1994 Mar; 61(2):203-11. PubMed ID: 8169569 [TBL] [Abstract][Full Text] [Related]